https://www.selleckchem.com/pr....oducts/5-n-ethyl-n-i
6%) were case-control studies, 3(9.6%) were randomised controlled trials and 1(3.2%) was systematic review and meta-analysis. In terms of major risk factors, genetic mutations were cited by 4(12.9%) studies, infections and inflammatory biomarkers by 15(48.4%), nutritional deficiencies by 9(29%) and geographical and socioeconomic status by 3(9.6%) studies. Early identification and recognition of risk factors associated with pulmonary exacerbation can have an explicit impact on its management, leading to decre
Beğen
Yorum Yap
Paylaş
